TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/24 19:26 | 9/3/24 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Milne George M Jr | MA | D | P | 220 | 2.20 | 0 | 100 | 13 | 859 | D | |||||||||||||||
5/23/23 17:16 | 5/18/23 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Milne George M Jr | A0 | D | M.d | 0 | 0.00 | 0 | 9 | 12 | 79 | D | ||||||||||||||||
3/20/23 20:25 | 3/16/23 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Milne George M Jr | MA | D | S | -1,116 | 31.89 | 0 | -35 | -4 | 862 | D | |||||||||||||||
3/6/23 16:29 | 3/2/23 | AUPH | Aurinia Pharmaceuticals Inc. | A0 | Health | Drug | Pharmaceutical Preparations | Milne George M Jr | A1 | D | P | 178 | 8.91 | 0 | 20 | 40 | 70 | D | |||||||||||||||
3/8/22 16:06 | 3/4/22 | AUPH | Aurinia Pharmaceuticals Inc. | A0 | Health | Drug | Pharmaceutical Preparations | Milne George M Jr | A1 | D | P | 54 | 10.82 | 0 | 5 | 11 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |